10.3 Perspectives: from a single drug to an adaptive precision-care paradigm Future progress in this field will depend not only on more effective agents, but also on higher-quality reproductive evidence and better integration of metabolic, reproductive, and safety endpoints into clinical pathway design
"Star-News - Google News Archive Search"
This is due to possible bacterial contamination and reduced potency over time
What Lisa learned from Eleven Madison Parks rise to #1
CrossRef A Case of von HippelLindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas Su Jin Heo, Choong-kun Lee, Kyu Yeon Hahn, Gyuri Kim, Hyuk Hur, Sung Hoon Choi, Kyung Seok Han, Arthur Cho, Minkyu Jung Cancer Research and Treatment.2016